ASRT
Price
$0.63
Change
+$0.01 (+1.61%)
Updated
Jun 13 closing price
Capitalization
91.13M
47 days until earnings call
TLRY
Price
$0.40
Change
-$0.02 (-4.76%)
Updated
Jun 13 closing price
Capitalization
1.87B
39 days until earnings call
Interact to see
Advertisement

ASRT vs TLRY

Header iconASRT vs TLRY Comparison
Open Charts ASRT vs TLRYBanner chart's image
Assertio Holdings
Price$0.63
Change+$0.01 (+1.61%)
Volume$231.26K
Capitalization91.13M
Tilray Brands
Price$0.40
Change-$0.02 (-4.76%)
Volume$11.23M
Capitalization1.87B
ASRT vs TLRY Comparison Chart
Loading...
ASRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASRT vs. TLRY commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASRT is a Hold and TLRY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (ASRT: $0.63 vs. TLRY: $0.40)
Brand notoriety: ASRT: Not notable vs. TLRY: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ASRT: 83% vs. TLRY: 44%
Market capitalization -- ASRT: $91.13M vs. TLRY: $1.87B
ASRT [@Pharmaceuticals: Other] is valued at $91.13M. TLRY’s [@Pharmaceuticals: Other] market capitalization is $1.87B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASRT’s FA Score shows that 0 FA rating(s) are green whileTLRY’s FA Score has 0 green FA rating(s).

  • ASRT’s FA Score: 0 green, 5 red.
  • TLRY’s FA Score: 0 green, 5 red.
According to our system of comparison, TLRY is a better buy in the long-term than ASRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASRT’s TA Score shows that 5 TA indicator(s) are bullish while TLRY’s TA Score has 5 bullish TA indicator(s).

  • ASRT’s TA Score: 5 bullish, 5 bearish.
  • TLRY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TLRY is a better buy in the short-term than ASRT.

Price Growth

ASRT (@Pharmaceuticals: Other) experienced а -4.52% price change this week, while TLRY (@Pharmaceuticals: Other) price change was -0.39% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.42%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +67.02%.

Reported Earning Dates

ASRT is expected to report earnings on Jul 31, 2025.

TLRY is expected to report earnings on Oct 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.42% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLRY($1.87B) has a higher market cap than ASRT($91.1M). TLRY has higher P/E ratio than ASRT: TLRY (8.52) vs ASRT (1.21). ASRT YTD gains are higher at: -27.460 vs. TLRY (-69.624). ASRT has higher annual earnings (EBITDA): -222.9M vs. TLRY (-1.23B). TLRY has more cash in the bank: 260M vs. ASRT (73.4M). ASRT has less debt than TLRY: ASRT (39.7M) vs TLRY (529M). TLRY has higher revenues than ASRT: TLRY (700M) vs ASRT (152M).
ASRTTLRYASRT / TLRY
Capitalization91.1M1.87B5%
EBITDA-222.9M-1.23B18%
Gain YTD-27.460-69.62439%
P/E Ratio1.218.5214%
Revenue152M700M22%
Total Cash73.4M260M28%
Total Debt39.7M529M8%
FUNDAMENTALS RATINGS
ASRT vs TLRY: Fundamental Ratings
ASRT
TLRY
OUTLOOK RATING
1..100
585
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9293
PRICE GROWTH RATING
1..100
6493
P/E GROWTH RATING
1..100
9894
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TLRY's Valuation (47) in the Biotechnology industry is in the same range as ASRT (79) in the Pharmaceuticals Major industry. This means that TLRY’s stock grew similarly to ASRT’s over the last 12 months.

TLRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ASRT (100) in the Pharmaceuticals Major industry. This means that TLRY’s stock grew similarly to ASRT’s over the last 12 months.

ASRT's SMR Rating (92) in the Pharmaceuticals Major industry is in the same range as TLRY (93) in the Biotechnology industry. This means that ASRT’s stock grew similarly to TLRY’s over the last 12 months.

ASRT's Price Growth Rating (64) in the Pharmaceuticals Major industry is in the same range as TLRY (93) in the Biotechnology industry. This means that ASRT’s stock grew similarly to TLRY’s over the last 12 months.

TLRY's P/E Growth Rating (94) in the Biotechnology industry is in the same range as ASRT (98) in the Pharmaceuticals Major industry. This means that TLRY’s stock grew similarly to ASRT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASRTTLRY
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 6 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 27 days ago
80%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ASRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YGRAF0.730.01
+1.77%
Yangarra Resources Ltd.
UNCRY32.31-0.65
-1.97%
UniCredito Spa
AHEXY14.23-0.39
-2.67%
Adecco Group AG
SGBLY12.70-0.61
-4.62%
Standard Bank Group Ltd.
CYTOF0.07-0.01
-11.25%
Altamira Therapeutics Ltd.

ASRT and

Correlation & Price change

A.I.dvisor tells us that ASRT and OGI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ASRT and OGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASRT
1D Price
Change %
ASRT100%
+2.43%
OGI - ASRT
28%
Poorly correlated
-4.76%
SNOA - ASRT
27%
Poorly correlated
-2.22%
AQST - ASRT
27%
Poorly correlated
+3.32%
TLRY - ASRT
26%
Poorly correlated
-2.95%
INDV - ASRT
26%
Poorly correlated
-0.29%
More

TLRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TLRY has been closely correlated with SNDL. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if TLRY jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLRY
1D Price
Change %
TLRY100%
-2.95%
SNDL - TLRY
76%
Closely correlated
-4.44%
CGC - TLRY
64%
Loosely correlated
-3.27%
CRON - TLRY
60%
Loosely correlated
-3.02%
OGI - TLRY
60%
Loosely correlated
-4.76%
ACB - TLRY
57%
Loosely correlated
-3.94%
More